The Global Phacoemulsification Market is Estimated to be Valued at US$ 385 Million in the Year 2027
Industry Insights
According to this new report, the global phacoemulsification market is estimated to be valued at US$ 385 million in the year 2027, growing at a CAGR of 4.5% in the period 2020 to 2027. Growth of the market is driven by the prevalence of cataract cases, the rise in the number of diabetics, the increasing geriatric population and the minimally invasive nature of the procedure.
Phacoemulsification is a modern cataract surgery which deals with emulsification or liquefaction of the natural lens of the eye. It uses an ultrasonic probe to break up and remove a cloudy lens, or cataract from the eyes. The technique has become a gold standard for cataract surgery globally due to its relatively higher visual rehabilitation outcome.
Technological prowess in the ophthalmology industry has led to the development of new advanced phacoemulsification systems with exceptional versatility. These systems portray simplified graphical UI, wireless remote control and various other advanced features.
Report Scope
This report “Global Phacoemulsification Market (By Products - Phacoemulsification Systems & Phacoemulsification Consumables; By Region- North America, Europe & Asia Pacific) Market Outlook 2027” provides detailed analysis of the global phacoemulsification market from qualitative and quantitative outlooks during the forecast period across various market segments and regional markets. It also provides coverage on market dynamics with potential impact on the market during the forecast period and an in-depth analysis of the leading companies operating in the market.
Parameter Description
- Base year: 2016
- Forecast period: 2020 - 2027
- Market sizing: Revenue in US$ Millions & CAGR for the period 2016 to 2027
- Vendor scope: Bausch Health Companies Inc., Carl Zeiss Meditec AG, Alcon Inc., Johnson & Johnson, Nidek Co. Ltd., Novartis AG
- Report coverage: Revenue forecast, market share analysis, company analysis, competitive landscape, market growth drivers, market restraints, market trends and company profiles
Segments Covered
The report provides revenue forecasts for global, regional and country levels. It also provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. For the purpose of research, the publisher has segmented the global phacoemulsification market report on the basis of geography and product types.
Product Type Outlook, Revenue (2016 - 2027E, US$ Millions)
- Phacoemulsification Systems
- Phacoemulsification Consumables
Regional Outlook, Revenue (2019 - 2027E, US$ Millions)
- North America
- Europe
- Asia Pacific
Vendors Outlook, Revenue (2015 - 2019, US$ Billions)
- Bausch Health Companies Inc.
- Carl Zeiss Meditec AG
- Alcon Inc.
- Johnson & Johnson
- Nidek Co. Ltd.
- Novartis AG
Target Audience
- Device Manufacturers
- Drug Manufacturers
- End Users
- Research Professionals
- Healthcare Consultancies
- Regulatory Bodies
Key Questions Answered in the Report
- The historical market size of the phacoemulsification market from 2016 to 2019 in US$ Millions.
- Projected market growth in the forecasted period 2020 to 2027 with estimated revenue for each year in US$ Millions.
- The regional analysis of the phacoemulsification market is provided for the period 2019 to 2027.
- Market drivers, restraints and industry trends that have an impact on revenue.
- Profiling of major companies with a detailed analysis of their phacoemulsification devices.
Table of Contents
1. Executive Summary2. Research Methodology
Executive Summary
A cataract is an eye disease which is caused due to opacification of the lens of the eye. It is the most common form of blindness globally. There are three primary types of age-related cataracts: nuclear sclerotic, cortical, and posterior subcapsular. With aging, any one type, or a combination of any of these three types of cataracts tends to develop in an individual. Treatment of cataract is only possible through surgical intervention. There are three basic techniques for cataract surgery - Phacoemulsification, Extracapsular cataract surgery and Intracapsular cataract surgery. Phacoemulsification is the most common form of cataract removal.
Phacoemulsification surgical procedure is a microincision modern cataract surgical method that is minimally invasive in nature with excellent visual outcomes, patient safety, and efficacy. Growth of phacoemulsification surgery for cataract treatment is attributed to prevalence of cataract cases, the rise in number of diabetics, the increasing geriatric population and the minimally invasive nature of the procedure. However, the market faces several challenges due to stringent regulatory compliance, the possibility of post-surgical complications and side-effects, lack of awareness of the procedure and a dearth of skilled professionals.
The report “Global Phacoemulsification Market (By Products - Phacoemulsification Systems & Phacoemulsification Consumables; By Region- North America, Europe & Asia Pacific) Market Outlook 2027” provides an in-depth analysis of the current scenario, detailed market outlook of the global phacoemulsification market. The market is segmented by products into Phacoemulsification Systems & Phacoemulsification Consumables. Future forecasts of the phacoemulsification market overall and across various regional markets have been provided in the report until 2027. Furthermore, major industry players have been prudently analyzed in the competitive landscape section of the report in order to provide key comparative insights.
Major industry players operating in the global phacoemulsification market include Bausch Health Companies Inc., Carl Zeiss Meditec AG, Alcon Inc., Johnson & Johnson, Nidek Co. Ltd., Novartis AG, among others. These players are profiled herein based on attributes such as business overview, product segments and financial analysis. It also compiles the performance comparison of the aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section. In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in the global phacoemulsification market.
Companies Mentioned
- Alcon Inc.
- Bausch Health Companies Inc.
- Carl Zeiss Meditec AG
- Johnson & Johnson
- Nidek Co., Ltd.
- Novartis AG
Methodology
LOADING...